• L&C Bio executive Lee Kwang-In held 76,882 shares as of Oct. 30, 2026, up from 33,851; his stake remained 0.13%.
• He acquired 4,590 common shares through a rights offering at 39,100 won each on Oct. 23.
• A one-for-one bonus issue added 38,441 common shares on Oct. 27.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. L&C Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030000176), on October 30, 2026, and is solely responsible for the information contained therein.